{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:33:01Z","timestamp":1787146381695,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1157\/13106935","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T12:48:30Z","timestamp":1182516510000},"page":"41-45","source":"Crossref","is-referenced-by-count":20,"title":["Enfermedad neumoc\u00f3cica invasiva en la poblaci\u00f3n menor de 5 a\u00f1os de edad de Navarra (2000-2005): impacto de la vacuna conjugada"],"prefix":"10.1016","volume":"129","author":[{"given":"Aurelio","family":"Barricarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gil-Setas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Torroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Arriazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Irisarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Garc\u00eda Cenoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1157\/13106935_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumoccocal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1157\/13106935_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13106935_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13106935_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"key":"10.1157\/13106935_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13106935_bib6","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13106935_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.inf.0000157090.40719.9b","article-title":"Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine","volume":"24","author":"Haddy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13106935_bib8","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1157\/13106935_bib9","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1157\/13106935_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(06)70520-5","article-title":"Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old","volume":"6","author":"Jefferson","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1157\/13106935_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1695-4033(02)77779-5","article-title":"La enfermedad neumoc\u00f3cica y su prevenci\u00f3n. Vacuna neumoc\u00f3cica conjugada heptavalente","volume":"56","year":"2002","journal-title":"An Esp Pediatr"},{"key":"10.1157\/13106935_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-0691.2006.1502_1.x","article-title":"Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine","volume":"12","author":"Calbo","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13106935_bib13","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/JCM.36.12.3447-3454.1998","article-title":"Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990-1996)","volume":"36","author":"Fenoll","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13106935_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13106935_bib15","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study","volume":"361","author":"Veenhoven","year":"2003","journal-title":"Lancet"},{"key":"10.1157\/13106935_bib16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1157\/13106935_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children\u2019s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1157\/13106935_bib18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1157\/13106935_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/500941","article-title":"Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia","volume":"42","author":"Steenhoff","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13106935_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.inf.0000207484.52850.38","article-title":"Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine","volume":"25","author":"Gonz\u00e1lez","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13106935_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13106935_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.inf.0000148891.32134.36","article-title":"and Massachusetts Department of Public Health Epidemiologists. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine","volume":"24","author":"Hsu","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13106935_bib23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/315096","article-title":"Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants","volume":"180","author":"Yu","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1157\/13106935_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/322984","article-title":"Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants","volume":"184","author":"Vakevainen","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1157\/13106935_bib25","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/498043","article-title":"Beall B and the Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States","volume":"192","author":"Pai","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1157\/13106935_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"K\u00e4ythy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1157\/13106935_bib27","unstructured":"Minist\u00e8re de la Sant\u00e9, et des Solidarit\u00e9s. Avis du Conseil Sup\u00e9rieur d\u2019Hygi\u00e8ne Publique de France. Relatif \u00e0 la vaccination par le vaccine antipneumococcique conjugu\u00e9 chez les enfants de moins de deux ans, et les enfants de deux \u00e0 cinq ans. S\u00e9ance du 19 mai 2006 [consultado 20\/11\/2006]. Disponible en: http:\/\/nosobase.chu-lyon.fr\/recommandations\/RCSHPF\/a_mt_190506_pneumo_enf.pdf"},{"key":"10.1157\/13106935_bib28","doi-asserted-by":"crossref","unstructured":"Bergsaker MAR, Feiring B. Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme. Euro Surveill. 2006; 11:E060202.5 [consultado 04\/08\/2006]. Disponible en: http:\/\/www.eurosurveillance.org\/ew\/2006\/060202.asp","DOI":"10.2807\/esw.11.05.02893-en"},{"key":"10.1157\/13106935_bib29","doi-asserted-by":"crossref","unstructured":"Cameron C, Pebody R. Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules. Euro Surveill. 2006; 11:E060302.4 [consultado 04\/08\/2006]. Disponible en: http:\/\/www.eurosurveillance.org\/ew\/2006\/060302.asp","DOI":"10.2807\/esw.11.09.02913-en"},{"key":"10.1157\/13106935_bib30","doi-asserted-by":"crossref","unstructured":"Van Oosten M, De Greeff SC, Spanjaard L, Schouls LM. Introduction of pneumococcal conjugate vaccine into the Dutch national immunization programme. Euro Surveill. 2006; 11:E060608.2 [consultado 04\/08\/2006]. Disponible en: http:\/\/www.eurosurveillance.org\/ew\/2006\/060608.asp","DOI":"10.2807\/esw.11.23.02968-en"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307727525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307727525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T08:33:53Z","timestamp":1587630833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307727525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0025775307727525"],"URL":"https:\/\/doi.org\/10.1157\/13106935","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}